(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 2.54% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 0.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.
Innospec's revenue in 2025 is $1,845,400,000.On average, 2 Wall Street analysts forecast IOSP's revenue for 2025 to be $47,231,162,726, with the lowest IOSP revenue forecast at $47,188,731,305, and the highest IOSP revenue forecast at $47,273,594,146.
In 2026, IOSP is forecast to generate $50,437,230,924 in revenue, with the lowest revenue forecast at $49,732,120,558 and the highest revenue forecast at $51,142,341,291.